IRIS

Sfoglia per Rivista  UROLOGIC ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 103
Titolo Data di pubblicazione Autore(i) File
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 1-gen-2021 Marandino, L.; Capozza, A.; Bandini, M.; Raggi, D.; Fare, E.; Pederzoli, F.; Gallina, A.; Capitanio, U.; Bianchi, M.; Gandaglia, G.; Fossati, N.; Colecchia, M.; Giannatempo, P.; Serafini, G.; Padovano, B.; Salonia, A.; Briganti, A.; Montorsi, F.; Alessi, A.; Necchi, A.
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 1-gen-2014 Bianchi, M; Gandaglia, G; Trinh, Qd; Hansen, J; Becker, A; Abdollah, F; Tian, Z; Lughezzani, G; Roghmann, F; Briganti, A; Montorsi, Francesco; Karakiewicz, Pi; Sun, M.
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis: Effect on survival and complication rates 1-gen-2019 Mistretta, F. A.; Mazzone, E.; Palumbo, C.; Knipper, S.; Tian, Z.; Nazzani, S.; Tilki, D.; Musi, G.; Perrotte, P.; Montanari, E.; Shariat, S. F.; Saad, F.; Briganti, A.; de Cobelli, O.; Karakiewicz, P. I.
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification 1-gen-2017 Leyh-Bannurah, Sami-Ramzi; Budäus, Lars; Zaffuto, Emanuele; Pompe, Raisa S.; Bandini, Marco; Briganti, Alberto; Montorsi, Francesco; Schiffmann, Jonas; Shariat, Shahrokh F.; Fisch, Margit; Chun, Felix; Huland, Hartwig; Graefen, Markus; Karakiewicz, Pierre I.
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 1-gen-2021 Mazzone, E.; Stabile, A.; Sorce, G.; Pellegrino, F.; Barletta, F.; Motterle, G.; Scuderi, S.; Cirulli, G. O.; Cucchiara, V.; Brembilla, G.; Esposito, A.; Gandaglia, G.; Fossati, N.; De Cobelli, F.; Montorsi, F.; Karnes, R. J.; Guccini, I.; Briganti, A.
Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy 1-gen-2020 Bravi, Carlo Andrea; Tin, Amy; Vertosick, Emily; Mazzone, Elio; Bandini, Marco; Dell'Oglio, Paolo; Stabile, Armando; Gandaglia, Giorgio; Fossati, Nicola; Sjoberg, Daniel; Touijer, Karim; Cozzarini, Cesare; Briganti, Alberto; Montorsi, Francesco; Eastham, James; Vickers, Andrew
Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use 1-gen-2016 Giganti, F; Coppola, A; Ambrosi, Alessandro; Ravelli, S; Esposito, Antonio; Freschi, M; Briganti, Alberto; Scattoni, V; Salonia, Andrea; Gallina, A; Dehò, F; Cardone, G; Balconi, G; Gaboardi, F; Montorsi, Francesco; DEL MASCHIO, Alessandro; DE COBELLI, Francesco
Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping 1-gen-2017 Gandaglia, Giorgio; Karnes, R. Jeffrey; Sivaraman, Arjun; Moschini, Marco; Fossati, Nicola; Zaffuto, Emanuele; Dellʼoglio, Paolo; Cathelineau, Xavier; Montorsi, Francesco; Sanchez-Salas, Rafael; Briganti, Alberto
Assessing the clinical benefit of a nomogram to predict specimen-confined disease at radical prostatectomy in patients with high-risk prostate cancer: An external validation 1-gen-2015 Hansen, Jens; Becker, Andreas; Kluth Luis, A; Rink, Michael; Steuber, Thomas; Zacharias, Mario; Briganti, Alberto; Fisch, Margit; Graefen, Markus; Chun Felix, K. H.
Bladder cancer incidence rates and trends in young adults aged 20-39 years 1-gen-2020 Palumbo, C.; Pecoraro, A.; Rosiello, G.; Luzzago, S.; Deuker, M.; Stolzenbach, F.; Tian, Z.; Shariat, S. F.; Simeone, C.; Briganti, A.; Saad, F.; Berruti, A.; Antonelli, A.; Karakiewicz, P. I.
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 1-gen-2022 Basile, G.; Bandini, M.; Raggi, D.; Marandino, L.; Pederzoli, F.; Salonia, A.; Briganti, A.; Montorsi, F.; Kulkarni, S. B.; Necchi, A.
Can we expand active surveillance criteria to include biopsy Gleason 3+4 prostate cancer? A multi-institutional study of 2,323 patients 1-gen-2015 Ploussard, Guillaume; Isbarn, Hendrik; Briganti, Alberto; Sooriakumaran, Prasanna; Surcel, Christian I.; Salomon, Laurent; Freschi, Massimo; Mirvald, Cristian; van der Poel, Henk G.; Jenkins, Anna; Ost, Piet; van Oort, Inge M.; Yossepowitch, Ofer; Giannarini, Gianluca; van den Bergh, Roderick C. N.
Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer 1-gen-2017 Soria, Francesco; Lucca, Ilaria; Moschini, Marco; Mathieu, Romain; Rouprêt, Morgan; Karakiewicz, Pierre I.; Briganti, Alberto; Rink, Michael; Gust, Kilian M.; Hassler, Melanie R.; Foerster, Beat; Abufarraj, Mohammad; Haitel, Andrea; Klatte, Tobias; Shariat, Shahrokh F.
Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy 1-gen-2018 D'Andrea, D.; Soria, F.; Abufaraj, M.; Gust, K.; Foerster, B.; Vartolomei, M. D.; Kimura, S.; Mari, A.; Briganti, A.; Remzi, M.; Seitz, C. K.; Mathieu, R.; Karakiewicz, P. I.; Shariat, S. F.
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 1-gen-2022 Basile, Giuseppe; Rosiello, Giuseppe; Larcher, Alessandro; Fallara, Giuseppe; Martini, Alberto; Re, Chiara; Cignoli, Daniele; Tian, Zhe; Karakiewicz, Pierre I; Mottrie, Alexandre; Bertini, Roberto; Necchi, Andrea; Raggi, Daniele; Salonia, Andrea; Briganti, Alberto; Montorsi, Francesco; Capitanio, Umberto
Combining anticancer drugs with osteoprotective agents in prostate cancer-A contemporary update 1-gen-2018 Tsaur, I; Heidegger, I; Kretschmer, A; Borgmann, H; Mirvald, C; Gandaglia, G; Briganti, A; van den Bergh, R; Tilki, D; Ost, P; Ploussard, G; Surcel, C
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 1-gen-2021 Pecoraro, A.; Deuker, M.; Rosiello, G.; Stolzenbach, F.; Luzzago, S.; Tian, Z.; Shariat, S. F.; Saad, F.; Briganti, A.; Kapoor, A.; Fiori, C.; Porpiglia, F.; Karakiewicz, P. I.
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates 1-gen-2021 Colla Ruvolo, C.; Stolzenbach, L. F.; Nocera, L.; Deuker, M.; Mistretta, F. A.; Luzzago, S.; Tian, Z.; Longo, N.; Graefen, M.; Chun, F. K. H.; Saad, F.; Briganti, A.; De Cobelli, O.; Mirone, V.; Karakiewicz, P. I.
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 1-gen-2023 Rosiello, G.; Larcher, A.; Fallara, G.; Cignoli, D.; Re, C.; Martini, A.; Tian, Z.; Karakiewicz, P. I.; Mottrie, A.; Boarin, M.; Villa, G.; Trevisani, F.; Marandino, L.; Raggi, D.; Necchi, A.; Bertini, R.; Salonia, A.; Briganti, A.; Montorsi, F.; Capitanio, U.
Comprehensive genomic profiling of histologic subtypes of urethral carcinomas 1-gen-2021 Jacob, J.; Necchi, A.; Grivas, P.; Hughes, M.; Sanford, T.; Mollapour, M.; Shapiro, O.; Talal, A.; Sokol, E.; Vergilio, J. -A.; Killian, J.; Lin, D.; Williams, E.; Tse, J.; Ramkissoon, S.; Severson, E.; Hemmerich, A.; Ferguson, N.; Edgerly, C.; Duncan, D.; Huang, R.; Chung, J.; Madison, R.; Alexander, B.; Venstrom, J.; Reddy, P.; Mcgregor, K.; Elvin, J.; Schrock, A.; Danziger, N.; Pavlick, D.; Ross, J.; Bratslavsky, G.
Mostrati risultati da 1 a 20 di 103
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile